645 related articles for article (PubMed ID: 28700807)
21. Attention-deficit/hyperactivity disorder in children following prenatal exposure to antidepressants: results from the Norwegian mother, father and child cohort study.
Lupattelli A; Mahic M; Handal M; Ystrom E; Reichborn-Kjennerud T; Nordeng H
BJOG; 2021 Nov; 128(12):1917-1927. PubMed ID: 33982858
[TBL] [Abstract][Full Text] [Related]
22. Antidepressant Use in Pregnancy and the Risk of Attention Deficit with or without Hyperactivity Disorder in Children.
Boukhris T; Sheehy O; Bérard A
Paediatr Perinat Epidemiol; 2017 Jul; 31(4):363-373. PubMed ID: 28640459
[TBL] [Abstract][Full Text] [Related]
23. Examining the Association of Antidepressant Prescriptions With First Abortion and First Childbirth.
Steinberg JR; Laursen TM; Adler NE; Gasse C; Agerbo E; Munk-Olsen T
JAMA Psychiatry; 2018 Aug; 75(8):828-834. PubMed ID: 29847626
[TBL] [Abstract][Full Text] [Related]
24. Prenatal Antidepressant Exposure and Offspring Brain Morphologic Trajectory.
Koc D; Tiemeier H; Stricker BH; Muetzel RL; Hillegers M; El Marroun H
JAMA Psychiatry; 2023 Dec; 80(12):1208-1217. PubMed ID: 37647036
[TBL] [Abstract][Full Text] [Related]
25. Antidepressant use during pregnancy and psychiatric disorders in offspring: Danish nationwide register based cohort study.
Liu X; Agerbo E; Ingstrup KG; Musliner K; Meltzer-Brody S; Bergink V; Munk-Olsen T
BMJ; 2017 Sep; 358():j3668. PubMed ID: 28877907
[No Abstract] [Full Text] [Related]
26. Antidepressant use during pregnancy and asthma in the offspring.
Liu X; Olsen J; Pedersen LH; Agerbo E; Yuan W; Li J
Pediatrics; 2015 Apr; 135(4):e911-7. PubMed ID: 25755245
[TBL] [Abstract][Full Text] [Related]
27. Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Risk for Attention-Deficit/Hyperactivity Disorder in Offspring.
Christensen J; Pedersen L; Sun Y; Dreier JW; Brikell I; Dalsgaard S
JAMA Netw Open; 2019 Jan; 2(1):e186606. PubMed ID: 30646190
[TBL] [Abstract][Full Text] [Related]
28. Paternal antidepressant use as a negative control for maternal use: assessing familial confounding on gestational length and anxiety traits in offspring.
Cohen JM; Wood ME; Hernández-Díaz S; Ystrom E; Nordeng H
Int J Epidemiol; 2019 Oct; 48(5):1665-1672. PubMed ID: 31369122
[TBL] [Abstract][Full Text] [Related]
29. Association Between Hypertensive Disorders of Pregnancy and Neurodevelopmental Outcomes Among Offspring.
Brand JS; Lawlor DA; Larsson H; Montgomery S
JAMA Pediatr; 2021 Jun; 175(6):577-585. PubMed ID: 33749704
[TBL] [Abstract][Full Text] [Related]
30. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
Singal D; Brownell M; Chateau D; Ruth C; Katz LY
BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
[TBL] [Abstract][Full Text] [Related]
31. Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication.
Lewis AJ; Galbally M; Opie G; Buist A
Aust N Z J Psychiatry; 2010 May; 44(5):482-7. PubMed ID: 20397792
[TBL] [Abstract][Full Text] [Related]
32. Association between antidepressant drug use during pregnancy and child healthcare utilisation.
Ververs TF; van Wensen K; Freund MW; van der Heide M; Visser GH; Schobben AF; de Jong-van den Berg LT; Egberts AC
BJOG; 2009 Nov; 116(12):1568-77. PubMed ID: 19681852
[TBL] [Abstract][Full Text] [Related]
33. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
Bérard A; Zhao JP; Sheehy O
BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
[TBL] [Abstract][Full Text] [Related]
34. Prenatal antidepressant exposure and child development at kindergarten age: a population-based study.
Park M; Hanley GE; Guhn M; Oberlander TF
Pediatr Res; 2021 May; 89(6):1515-1522. PubMed ID: 33299120
[TBL] [Abstract][Full Text] [Related]
35. Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age.
Grzeskowiak LE; Gilbert AL; Sørensen TI; Olsen J; Sørensen HT; Pedersen LH; Morrison JL
Ann Epidemiol; 2013 Nov; 23(11):681-7. PubMed ID: 24113367
[TBL] [Abstract][Full Text] [Related]
36. Prenatal antidepressant exposure and risk of spontaneous abortion - a population-based study.
Kjaersgaard MI; Parner ET; Vestergaard M; Sørensen MJ; Olsen J; Christensen J; Bech BH; Pedersen LH
PLoS One; 2013; 8(8):e72095. PubMed ID: 24015208
[TBL] [Abstract][Full Text] [Related]
37. Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects.
Anderson KN; Lind JN; Simeone RM; Bobo WV; Mitchell AA; Riehle-Colarusso T; Polen KN; Reefhuis J
JAMA Psychiatry; 2020 Dec; 77(12):1246-1255. PubMed ID: 32777011
[TBL] [Abstract][Full Text] [Related]
38. Methodological considerations in assessing the effectiveness of antidepressant medication continuation during pregnancy using administrative data.
Swanson SA; Hernandez-Diaz S; Palmsten K; Mogun H; Olfson M; Huybrechts KF
Pharmacoepidemiol Drug Saf; 2015 Sep; 24(9):934-42. PubMed ID: 26045370
[TBL] [Abstract][Full Text] [Related]
39. Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: A study from The Norwegian Mother and Child Cohort Study.
Lupattelli A; Wood M; Lapane K; Spigset O; Nordeng H
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1266-1276. PubMed ID: 28815791
[TBL] [Abstract][Full Text] [Related]
40. Intellectual disability: population-based estimates of the proportion attributable to maternal alcohol use disorder during pregnancy.
O'Leary C; Leonard H; Bourke J; D'Antoine H; Bartu A; Bower C
Dev Med Child Neurol; 2013 Mar; 55(3):271-7. PubMed ID: 23241019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
